Lipoprotein lipase (LPL) deficiency is a rare monogenic disorder that manifests as severe hypertriglyceridemia. Whether or not LPL deficiency accelerates the development of atherosclerosis remains controversial. We herein report a 66-year-old woman who was homozygous for the R243H LPL mutation. She had developed multiple arterial aneurysms and systemic atherosclerosis despite good control of other atherogenic risk factors, including diabetes. Furthermore, although intensive pharmaceutical therapies had been minimally effective, medium chain triglyceride (MCT) therapy reduced the serum triglyceride levels. Thus, this case suggests important role that mutated LPL protein plays in the progression of atherosclerosis and that MCT therapy is potentially effective, even for severe hypertriglyceridemia due to LPL deficiency.

Download full-text PDF

Source
http://dx.doi.org/10.2169/internalmedicine.55.5239DOI Listing

Publication Analysis

Top Keywords

lpl deficiency
12
lipoprotein lipase
8
multiple arterial
8
arterial aneurysms
8
severe hypertriglyceridemia
8
hypertriglyceridemia lpl
8
mct therapy
8
lpl
5
deficiency
4
lipase deficiency
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!